Total Valuation
Vicapsys Life Sciences has a market cap or net worth of $46.94M. The enterprise value is $47.84M.
Market Cap$46.94M
Enterprise Value$47.84M
Share Statistics
Vicapsys Life Sciences has 32,371,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,371,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Vicapsys Life Sciences’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 22.05%.
Return on Equity (ROE)0.19
Return on Assets (ROA)-261.62
Return on Invested Capital (ROIC)22.05%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee0.00
Profits Per Employee-344.94K
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Vicapsys Life Sciences is ―. Vicapsys Life Sciences’s PEG ratio is 2.38.
PE Ratio―
PS Ratio0.00
PB Ratio-14.82
Price to Fair Value-14.82
Price to FCF-2.47K
Price to Operating Cash Flow-10.07K
PEG Ratio2.38
Income Statement
In the last 12 months, Vicapsys Life Sciences had revenue of 0.00 and earned -689.89K in profits. Earnings per share was -0.02.
Revenue0.00
Gross Profit0.00
Operating Income-651.80K
Pretax Income-689.89K
Net Income-689.89K
EBITDA-651.80K
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -5.09K and capital expenditures 5.00, giving a free cash flow of -5.09K billion.
Operating Cash Flow-5.09K
Free Cash Flow-5.09K
Free Cash Flow per Share>-0.01
Dividends & Yields
Vicapsys Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1103542.60
52-Week Price Change-18.08%
50-Day Moving Average1.46
200-Day Moving Average1.48
Relative Strength Index (RSI)53.15
Average Volume (3m)0.00
Important Dates
Vicapsys Life Sciences upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Vicapsys Life Sciences as a current ratio of <0.01, with Debt / Equity ratio of -17.59%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap0.01
Net Debt to EBITDA-0.95
Interest Coverage Ratio-17.11
Taxes
In the past 12 months, Vicapsys Life Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Vicapsys Life Sciences EV to EBITDA ratio is -82.35, with an EV/FCF ratio of -2.50K.
EV to Sales0.00
EV to EBITDA-82.35
EV to Free Cash Flow-2.50K
EV to Operating Cash Flow-2.50K
Balance Sheet
Vicapsys Life Sciences has $132.54K in cash and marketable securities with $624.35K in debt, giving a net cash position of -$491.80K billion.
Cash & Marketable Securities$132.54K
Total Debt$624.35K
Net Cash-$491.80K
Net Cash Per Share-$0.02
Tangible Book Value Per Share-$0.10
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Vicapsys Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―